Clinical Validation Archives

Potential Impact of the 70-gene Signature in the Choice of Adjuvant Systemic Treatment for ER Positive, HER2 Negative Tumors: a Single Institution Experience
Potential Impact of the 70-gene Signature in the Choice of Adjuvant Systemic Treatment for ER Positive, HER2 Negative Tumors: a Single Institution Experience

Adjuvant, Evidence, MammaPrint

Potential Impact of the 70-gene Signature in the Choice of Adjuvant Systemic Treatment for ER Positive, HER2 Negative Tumors: a Single Institution Experience

PUBLICATION: Breast. 2013 Aug;22(4):419-24. doi: 10.1016/j.breast.2013.03.013. Epub 2013 May 3. Read More

kevin2024-03-07T12:14:52-08:00August 1st, 2013|Adjuvant, Evidence, MammaPrint|

A Prospective Evaluation of a Breast Cancer Prognosis Signature in the Observational RASTER Study
A Prospective Evaluation of a Breast Cancer Prognosis Signature in the Observational RASTER Study

Adjuvant, Evidence, MammaPrint, RASTER

A Prospective Evaluation of a Breast Cancer Prognosis Signature in the Observational RASTER Study

PUBLICATION: Int J Cancer. 2013 Aug 15;133(4):929-36. doi: 10.1002/ijc.28082. Epub Read More

kevin2024-03-25T10:47:48-07:00January 13th, 2013|Adjuvant, Evidence, MammaPrint, RASTER|

Additional Value of the 70-gene Signature and Levels of ER and PR for the Prediction of Outcome in Tamoxifen-Treated, ER-Positive Breast Cancer
Additional Value of the 70-gene Signature and Levels of ER and PR for the Prediction of Outcome in Tamoxifen-Treated, ER-Positive Breast Cancer

Endocrine, Evidence, MammaPrint

Additional Value of the 70-gene Signature and Levels of ER and PR for the Prediction of Outcome in Tamoxifen-Treated, ER-Positive Breast Cancer

PUBLICATION: The Breast. 2012 Dec;21(6):769-78. doi: 10.1016/j.breast.2012.04.010. Epub 2012 Jun Read More

kevin2024-03-25T10:49:46-07:00December 1st, 2012|Endocrine, Evidence, MammaPrint|

Lobular Histology and Response to Neoadjuvant Chemotherapy in Invasive Breast Cancer
Lobular Histology and Response to Neoadjuvant Chemotherapy in Invasive Breast Cancer

Evidence, Lobular, MammaPrint, Neoadjuvant, Other

Lobular Histology and Response to Neoadjuvant Chemotherapy in Invasive Breast Cancer

PUBLICATION: Breast Cancer Res Treat. 2012 Nov;136(1):35-43. doi: 10.1007/s10549-012-2233-z. Epub Read More

kevin2024-03-25T10:51:13-07:00November 1st, 2012|Evidence, Lobular, MammaPrint, Neoadjuvant, Other|

Impact of Mammographic Screening on the Detection of Good and Poor Prognosis Breast Cancers
Impact of Mammographic Screening on the Detection of Good and Poor Prognosis Breast Cancers

Evidence, MammaPrint, Other

Impact of Mammographic Screening on the Detection of Good and Poor Prognosis Breast Cancers

PUBLICATION: Breast Cancer Res Treat. 2011 Dec;130(3):725-34. doi: 10.1007/s10549-011-1748-z. Epub Read More

kevin2024-03-25T10:55:45-07:00December 2nd, 2011|Evidence, MammaPrint, Other|

Use of a Genomic Test (MammaPrint™) in Daily Clinical Practice to Assist in Risk Stratification of Young Breast Cancer Patients
Gallery
Use of a Genomic Test (MammaPrint™) in Daily Clinical Practice to Assist in Risk Stratification of Young Breast Cancer Patients

Adjuvant, Evidence, MammaPrint

Use of a Genomic Test (MammaPrint™) in Daily Clinical Practice to Assist in Risk Stratification of Young Breast Cancer Patients

PUBLICATION: Arch Gynecol Obstet (2011) 283: 597. https://doi.org/10.1007/s00404-010-1454-9. AUTHORS: Kunz, Read More

kevin2024-03-25T10:56:57-07:00March 1st, 2011|Adjuvant, Evidence, MammaPrint|

Identification of a Low-Risk Subgroup of HER-2-Positive Breast Cancer by the 70-gene Prognosis Signature
Identification of a Low-Risk Subgroup of HER-2-Positive Breast Cancer by the 70-gene Prognosis Signature

Evidence, HER2-positive, MammaPrint, Other

Identification of a Low-Risk Subgroup of HER-2-Positive Breast Cancer by the 70-gene Prognosis Signature

PUBLICATION: Br J Cancer. 2010 Dec 7; 103(12): 1788–1793. Published Read More

kevin2024-03-07T11:51:48-08:00December 7th, 2010|Evidence, HER2-positive, MammaPrint, Other|

Comparison of MammaPrint and TargetPrint Results with Clinical Parameters in German Patients with Early Stage Breast Cancer
Gallery
Comparison of MammaPrint and TargetPrint Results with Clinical Parameters in German Patients with Early Stage Breast Cancer

Evidence, MammaPrint, Other

Comparison of MammaPrint and TargetPrint Results with Clinical Parameters in German Patients with Early Stage Breast Cancer

PUBLICATION: Int J Mol Med. 2010 Dec;26(6):837-43. AUTHORS: Gevensleben H., Read More

kevin2024-03-25T10:58:17-07:00December 1st, 2010|Evidence, MammaPrint, Other|

Metastatic Potential of T1 Breast Cancer Can Be Predicted by the 70-gene MammaPrint Signature
Metastatic Potential of T1 Breast Cancer Can Be Predicted by the 70-gene MammaPrint Signature

Adjuvant, Evidence, MammaPrint

Metastatic Potential of T1 Breast Cancer Can Be Predicted by the 70-gene MammaPrint Signature

PUBLICATION: Ann Surg Oncol. 2010 May;17(5):1406-13. doi: 10.1245/s10434-009-0902-x. Epub 2010 Read More

kevin2024-03-25T11:00:58-07:00May 1st, 2010|Adjuvant, Evidence, MammaPrint|

The 70-gene Signature as a Response Predictor for Neoadjuvant Chemotherapy in Breast Cancer
The 70-gene Signature as a Response Predictor for Neoadjuvant Chemotherapy in Breast Cancer

Evidence, MammaPrint, Neoadjuvant

The 70-gene Signature as a Response Predictor for Neoadjuvant Chemotherapy in Breast Cancer

PUBLICATION: Breast Cancer Res Treat. 2010 Feb;119(3):551-8. doi: 10.1007/s10549-009-0333-1. Epub Read More

kevin2024-03-25T11:03:35-07:00February 1st, 2010|Evidence, MammaPrint, Neoadjuvant|